| Pharmaceutical active ingredients: |
| Pentazocine Hydrochloride |
| Available forms, composition and doses of Rafazocine: |
| Injectable; Injection; Pentazocine Hydrochloride 3%Tablets; Oral; Pentazocine Hydrochloride 50 mg |
| Rafazocine medical category: |
| Human:Analgesics (opioid) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AD01 - Pentazocine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Rafa Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sosigon | Pentazocine | Unidentified Pharmaceutical Company |
| Talwan | Pentazocine | Unidentified Pharmaceutical Company |
| Zocin | Pentazocine | Ind-Swift |
| Peltazon | Pentazocine Hydrochloride | Grelan Pharmaceutical |
| Pentagin | Pentazocine Hydrochloride | Sankyo |
| Fortal | Pentazocine Hydrochloride; Pentazocine Lactate | Sanofi-Aventis; Institute of Pharmaceutical Research and Technology |
| Fortalgesic | Pentazocine Hydrochloride; Pentazocine Lactate | Sanofi-Aventis |
| Pangon | Pentazocine Hydrochloride; Pentazocine Lactate | LBS Laboratory |
| Sosegon | Pentazocine Hydrochloride; Pentazocine Lactate | Sanofi-Aventis; Yamanouchi |
| Talwin | Pentazocine Hydrochloride; Pentazocine Lactate | Sanofi-Aventis; Abbott; Hospira |